BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 6 filers reported holding BLUEBIRD BIO INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $450,000 | -32.2% | 7,300 | -25.5% | 0.25% | -61.8% |
| Q3 2016 | $664,000 | +56.6% | 9,800 | 0.0% | 0.66% | +18.6% |
| Q2 2016 | $424,000 | +4.7% | 9,800 | +55.6% | 0.56% | +123.2% |
| Q4 2015 | $405,000 | -76.8% | 6,300 | -39.3% | 0.25% | -77.0% |
| Q2 2015 | $1,746,000 | +37.7% | 10,371 | -1.2% | 1.09% | +28.4% |
| Q1 2015 | $1,268,000 | +70.7% | 10,500 | +29.6% | 0.85% | +111.5% |
| Q4 2014 | $743,000 | +89.1% | 8,100 | -26.1% | 0.40% | +43.9% |
| Q3 2014 | $393,000 | +45.6% | 10,957 | +9.6% | 0.28% | +68.5% |
| Q3 2013 | $270,000 | -58.0% | 10,000 | -61.2% | 0.16% | -63.9% |
| Q2 2013 | $643,000 | – | 25,750 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,964,000 | $59,215,000 | 1.36% |
| Birchview Capital, LP | 75,500 | $2,276,000 | 1.35% |
| Camber Capital Management LP | 1,000,000 | $30,150,000 | 1.04% |
| Sessa Capital IM, L.P. | 875,000 | $26,381,000 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $16,226,000 | 0.92% |
| Tarsadia Capital, LLC | 100,000 | $3,015,000 | 0.81% |
| Bullseye Asset Management LLC | 67,872 | $2,046,000 | 0.76% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,304,246 | $39,323,000 | 0.58% |
| MANGROVE PARTNERS IM, LLC | 175,178 | $5,282,000 | 0.53% |
| Parametrica Management Ltd | 37,712 | $1,080,000 | 0.52% |